ACT LAB Expands National Laboratory Network To New Jersey
Building on trusted local expertise, ACT LAB brings enhanced testing methodologies and regulatory guidance to New Jersey’s regulated cannabis market.
ACT LAB, a multistate cannabis and hemp testing and compliance laboratory network with more than 12 years in the cannabis testing space, announced its expansion into New Jersey. The move further advances the company’s strategy to deliver the consistent results, operational excellence, and responsive customer support that regulated cannabis businesses depend on. The expansion follows the acquisition of Sriven Labs (SV Labs – NJ), a licensed cannabis testing laboratory serving New Jersey’s regulated cannabis market.
New Jersey represents an important milestone in ACT LAB’s continued growth. As one of the nation’s fastest-growing regulated cannabis markets, the state provides a significant opportunity to bring ACT LAB’s best-in-class turnaround times and superior customer service to support operators, protect consumers, and strengthen confidence in regulated cannabis products.
“ACT LAB’s expansion in New Jersey builds on the strong customer relationships, local knowledge, and experienced team established by Sriven Labs, while adding the scientific depth and resources of one of the nation’s largest and most experienced cannabis testing laboratory networks,” said J. Michael Drozd, CEO of ACT LAB. “In addition to strengthening local testing capabilities, ACT LAB’s national laboratory network provides meaningful value for both multistate operators and independent cannabis businesses who operate in New Jersey.”
